미국의 임상 의사결정 지원 시스템(CDSS) 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 제공 형태별, 컴포넌트별, 부문별 예측(2025-2030년)

Market Size & Trends:

The U.S. clinical decision support systems market size was valued at USD 2.14 billion in 2024 and is projected to reach USD 3.40 billion by 2030, growing at a CAGR of 8.17% from 2025 to 2030. The widespread adoption of Electronic Health Records (EHRs) across U.S. hospitals and office-based physicians is significantly driving the market growth. According to Simbo AI, as of 2021, approximately 88% of office-based physicians in the U.S. had implemented an Electronic Health Record (EHR) system, more than doubling the adoption rate from just 42% in previous years, has paved the way for seamless integration of CDSS tools that offer real-time alerts, treatment recommendations, and drug interaction checks at the point of care. Moreover, strong policy support through initiatives like the HITECH Act, Meaningful Use incentives, certification programs from HHS, and provisions in the 21st Century Cures Act created a regulatory environment that incentivizes CDSS adoption and ensures interoperability while encouraging innovation.

To learn more about this report, request a free sample copy

Artificial intelligence (AI) and machine learning (ML) technologies are revolutionizing the clinical decision support systems (CDSS) market by providing enhanced features like predictive analytics, pattern recognition, and personalized recommendations. AI-powered CDSS processes large volumes of data, identifies trends, forecasts outcomes, and recommends the best treatment options. For instance, in December 2022, researchers at the University of Texas at Austin's Dell Medical School developed an AI-based CDSS designed to help clinicians engage patients in conversations about nutrition and support decision-making regarding dietary improvements.

Personalized medicine is on the rise, with CDSSs playing a key role. To create customized treatment plans, these systems evaluate patient information, such as genetic data and medical histories. By delivering personalized recommendations, CDSSs improve treatment outcomes and minimize the chances of adverse effects, contributing to the market's growth.

The COVID-19 pandemic has significantly driven the growth of the U.S. clinical decision support systems market, driving wider adoption of these tools. CDSSs were crucial in supporting patient care and resource management by aiding real-time clinical diagnosis and triage of COVID-19 cases. The expansion of online healthcare services across the country further accelerated this trend. Market leaders introduced specialized CDSS solutions for managing COVID-19 data and insights; for instance, in May 2022, Epocrates launched an advanced tool focused on long-term COVID, incorporating the latest clinical guidelines. This increased adoption has been a key factor in market growth during the pandemic.

U.S. Clinical Decision Support Systems Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. clinical decision support systems market report based on product, application, delivery mode, and component:

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Standalone CDSS
• Integrated CPOE with CDSS
• Integrated EHR with CDSS
• Integrated CDSS with CPOE and EHR
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Drug-Drug Interactions
• Drug Allergy Alerts
• Clinical Reminders
• Clinical Guidelines
• Drug Dosing Support
• Others
• Deliver Mode Outlook (Revenue, USD Million, 2018 - 2030)
• Web-Based Systems
• Cloud-Based Systems
• On-Premise Systems
• Component Outlook (Revenue, USD Million, 2018 - 2030)
• Hardware
• Software
• Services

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment Definitions
• 1.2. Estimates and Forecast Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of Primary Research
  • 1.4.6. Research Assumption
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Data Visualization
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
• 1.8. Objectives
  • 1.8.1. Objective - 1
  • 1.8.2. Objective - 2
  • 1.8.3. Objective - 3
• 1.9. List of Secondary Sources
• 1.10. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. U.S. Clinical Decision Support Systems Market
  • 2.1.1. Market Snapshot
  • 2.1.2. Segment Snapshot
    • 2.1.2.1. Product segment outlook
    • 2.1.2.2. Application segment outlook
    • 2.1.2.3. Delivery Mode segment outlook
    • 2.1.2.4. Component segment outlook
  • 2.1.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Rising Adoption of Electronic Health Records (EHRs)
    • 3.3.1.2. Increasing Demand for Quality Care and Patient Safety
    • 3.3.1.3. Advancements in AI and Machine Learning Technologies
    • 3.3.1.4. Supportive Government Initiatives and Healthcare IT Policies
    • 3.3.1.5. Integration of CDSS with Clinical Workflows
    • 3.3.1.6. Need to Reduce Medication Errors and Diagnostic Inaccuracies
    • 3.3.1.7. Emergence of Cloud-Based CDSS Solutions
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. High implementation and integration costs
    • 3.3.2.2. Data privacy and security concerns
    • 3.3.2.3. Interoperability challenges with legacy systems
  • 3.3.3. Market Opportunity Analysis
  • 3.3.4. Market Challenges Analysis
• 3.4. U.S. Clinical Decision Support Systems Market Analysis Tools: PESTEL
  • 3.4.1. Political & Legal
  • 3.4.2. Economic & Social
  • 3.4.3. Technology
• 3.5. U.S. Clinical Decision Support Systems Market Analysis Tools: Porter's

Chapter 4. U.S. Clinical Decision Support Systems Market: Product Estimates & Trend Analysis

• 4.1. U.S. Clinical Decision Support Systems Market: Product Movement Analysis
• 4.2. U.S. Clinical Decision Support Systems Market: Product Segment Dashboard
• 4.3. Product Movement & Market Share Analysis, 2024 & 2030
• 4.4. U.S. Clinical Decision Support Systems Market Estimates & Forecast, by Product
• 4.5. Standalone CDSS
  • 4.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 4.6. Integrated CPOE with CDSS
  • 4.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 4.7. Integrated EHR with CDSS
  • 4.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 4.8. Integrated CDSS with CPOE and HER
  • 4.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)

Chapter 5. U.S. Clinical Decision Support Systems Market: Application Estimates & Trend Analysis

• 5.1. U.S. Clinical Decision Support Systems Market: Application Movement Analysis
• 5.2. U.S. Clinical Decision Support Systems Market: Application Segment Dashboard
• 5.3. Application Movement & Market Share Analysis, 2024 & 2030
• 5.4. U.S. Clinical Decision Support Systems Market Estimates & Forecast, by Application
• 5.5. Drug-Drug Interactions
  • 5.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 5.6. Drug Allergy Alerts
  • 5.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 5.7. Clinical Reminders
  • 5.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 5.8. Clinical Guidelines
  • 5.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 5.9. Drug Dosing Support
  • 5.9.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 5.10. Others
  • 5.10.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)

Chapter 6. U.S. Clinical Decision Support Systems Market: Delivery Mode Estimates & Trend Analysis

• 6.1. U.S. Clinical Decision Support Systems Market: Delivery Mode Movement Analysis
• 6.2. U.S. Clinical Decision Support Systems Market: Delivery Mode Segment Dashboard
• 6.3. Delivery Mode Movement & Market Share Analysis, 2024 & 2030
• 6.4. U.S. Clinical Decision Support Systems Market Estimates & Forecast, by Delivery Mode
• 6.5. Web-Based Systems
  • 6.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 6.6. Cloud-Based Systems
  • 6.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 6.7. On-Premise Systems
  • 6.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)

Chapter 7. U.S. Clinical Decision Support Systems Market: Component Estimates & Trend Analysis

• 7.1. U.S. Clinical Decision Support Systems Market: Component Movement Analysis
• 7.2. U.S. Clinical Decision Support Systems Market: Component Segment Dashboard
• 7.3. Component Movement & Market Share Analysis, 2024 & 2030
• 7.4. U.S. Clinical Decision Support Systems Market Estimates & Forecast, by Component
• 7.5. Hardware
  • 7.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 7.6. Software
  • 7.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 7.7. Services
  • 7.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Company Market Position Analysis, 2024
• 8.3. Company Share Analysis
• 8.4. Company Profiles/Listing
  • 8.4.1. McKesson Corporation
    • 8.4.1.1. Participant's Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Recent Developments
  • 8.4.2. Cerner Corporation (now Oracle Health)
    • 8.4.2.1. Participant's Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Recent Developments
  • 8.4.3. Siemens Healthineers GmbH
    • 8.4.3.1. Participant's Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Recent Developments
  • 8.4.4. Allscripts Healthcare, LLC (now Veradigm)
    • 8.4.4.1. Participant's Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Recent Developments
  • 8.4.5. athenahealth, Inc.
    • 8.4.5.1. Participant's Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Recent Developments
  • 8.4.6. NextGen Healthcare Inc.
    • 8.4.6.1. Participant's Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Recent Developments
  • 8.4.7. IBM Corporation
    • 8.4.7.1. Participant's Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Recent Developments
  • 8.4.8. GE HealthCare
    • 8.4.8.1. Participant's Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Recent Developments
  • 8.4.9. Nordic
    • 8.4.9.1. Participant's Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Recent Developments
  • 8.4.10. BeeKeeperAI
    • 8.4.10.1. Participant's Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Recent Developments